Global Oncology Biosimilars Sales Market Report 2016

September 2016 | 121 pages | ID: G9872F98FE3EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Oncology Biosimilars

Revenue, means the sales value of Oncology Biosimilars

This report studies sales (consumption) of Oncology Biosimilars in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• 3SBio
• Biocon
• BioXpress Therapeutics
• Boehringer Ingelheim
• Celltrion
• Coherus Biosciences
• Dr. Reddy’s Laboratories
• Hospira
• Intas Pharmaceuticals
• Merck Serono
• Mylan
• Novartis (Sandoz)
• Pfizer
• Wockhardt

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Oncology Biosimilars in these regions, from 2011 to 2021 (forecast), like

• USA
• China
• Europe
• Japan
• India
• Southeast Asia

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Oncology Biosimilars in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Oncology Biosimilars Sales Market Report 2016

1 ONCOLOGY BIOSIMILARS OVERVIEW

1.1 Product Overview and Scope of Oncology Biosimilars
1.2 Classification of Oncology Biosimilars
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Oncology Biosimilars
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Oncology Biosimilars Market by Regions
  1.4.1 USA Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 India Status and Prospect (2011-2021)
  1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Oncology Biosimilars (2011-2021)
  1.5.1 Global Oncology Biosimilars Sales and Growth Rate (2011-2021)
  1.5.2 Global Oncology Biosimilars Revenue and Growth Rate (2011-2021)

2 GLOBAL ONCOLOGY BIOSIMILARS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Oncology Biosimilars Market Competition by Manufacturers
  2.1.1 Global Oncology Biosimilars Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global Oncology Biosimilars Revenue and Share by Manufacturers (2011-2016)
2.2 Global Oncology Biosimilars (Volume and Value) by Type
  2.2.1 Global Oncology Biosimilars Sales and Market Share by Type (2011-2016)
  2.2.2 Global Oncology Biosimilars Revenue and Market Share by Type (2011-2016)
2.3 Global Oncology Biosimilars (Volume and Value) by Regions
  2.3.1 Global Oncology Biosimilars Sales and Market Share by Regions (2011-2016)
  2.3.2 Global Oncology Biosimilars Revenue and Market Share by Regions (2011-2016)
2.4 Global Oncology Biosimilars (Volume) by Application

3 USA ONCOLOGY BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

3.1 USA Oncology Biosimilars Sales and Value (2011-2016)
  3.1.1 USA Oncology Biosimilars Sales and Growth Rate (2011-2016)
  3.1.2 USA Oncology Biosimilars Revenue and Growth Rate (2011-2016)
  3.1.3 USA Oncology Biosimilars Sales Price Trend (2011-2016)
3.2 USA Oncology Biosimilars Sales and Market Share by Manufacturers
3.3 USA Oncology Biosimilars Sales and Market Share by Type
3.4 USA Oncology Biosimilars Sales and Market Share by Application

4 CHINA ONCOLOGY BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

4.1 China Oncology Biosimilars Sales and Value (2011-2016)
  4.1.1 China Oncology Biosimilars Sales and Growth Rate (2011-2016)
  4.1.2 China Oncology Biosimilars Revenue and Growth Rate (2011-2016)
  4.1.3 China Oncology Biosimilars Sales Price Trend (2011-2016)
4.2 China Oncology Biosimilars Sales and Market Share by Manufacturers
4.3 China Oncology Biosimilars Sales and Market Share by Type
4.4 China Oncology Biosimilars Sales and Market Share by Application

5 EUROPE ONCOLOGY BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Oncology Biosimilars Sales and Value (2011-2016)
  5.1.1 Europe Oncology Biosimilars Sales and Growth Rate (2011-2016)
  5.1.2 Europe Oncology Biosimilars Revenue and Growth Rate (2011-2016)
  5.1.3 Europe Oncology Biosimilars Sales Price Trend (2011-2016)
5.2 Europe Oncology Biosimilars Sales and Market Share by Manufacturers
5.3 Europe Oncology Biosimilars Sales and Market Share by Type
5.4 Europe Oncology Biosimilars Sales and Market Share by Application

6 JAPAN ONCOLOGY BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Oncology Biosimilars Sales and Value (2011-2016)
  6.1.1 Japan Oncology Biosimilars Sales and Growth Rate (2011-2016)
  6.1.2 Japan Oncology Biosimilars Revenue and Growth Rate (2011-2016)
  6.1.3 Japan Oncology Biosimilars Sales Price Trend (2011-2016)
6.2 Japan Oncology Biosimilars Sales and Market Share by Manufacturers
6.3 Japan Oncology Biosimilars Sales and Market Share by Type
6.4 Japan Oncology Biosimilars Sales and Market Share by Application

7 INDIA ONCOLOGY BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

7.1 India Oncology Biosimilars Sales and Value (2011-2016)
  7.1.1 India Oncology Biosimilars Sales and Growth Rate (2011-2016)
  7.1.2 India Oncology Biosimilars Revenue and Growth Rate (2011-2016)
  7.1.3 India Oncology Biosimilars Sales Price Trend (2011-2016)
7.2 India Oncology Biosimilars Sales and Market Share by Manufacturers
7.3 India Oncology Biosimilars Sales and Market Share by Type
7.4 India Oncology Biosimilars Sales and Market Share by Application

8 SOUTHEAST ASIA ONCOLOGY BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Oncology Biosimilars Sales and Value (2011-2016)
  8.1.1 Southeast Asia Oncology Biosimilars Sales and Growth Rate (2011-2016)
  8.1.2 Southeast Asia Oncology Biosimilars Revenue and Growth Rate (2011-2016)
  8.1.3 Southeast Asia Oncology Biosimilars Sales Price Trend (2011-2016)
8.2 Southeast Asia Oncology Biosimilars Sales and Market Share by Manufacturers
8.3 Southeast Asia Oncology Biosimilars Sales and Market Share by Type
8.4 Southeast Asia Oncology Biosimilars Sales and Market Share by Application

9 GLOBAL ONCOLOGY BIOSIMILARS MANUFACTURERS ANALYSIS

9.1 3SBio
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Oncology Biosimilars Product Type, Application and Specification
    9.1.2.1 Type I
    9.1.2.2 Type II
  9.1.3 3SBio Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  9.1.4 Main Business/Business Overview
9.2 Biocon
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 121 Product Type, Application and Specification
    9.2.2.1 Type I
    9.2.2.2 Type II
  9.2.3 Biocon Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  9.2.4 Main Business/Business Overview
9.3 BioXpress Therapeutics
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 140 Product Type, Application and Specification
    9.3.2.1 Type I
    9.3.2.2 Type II
  9.3.3 BioXpress Therapeutics Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  9.3.4 Main Business/Business Overview
9.4 Boehringer Ingelheim
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Sep Product Type, Application and Specification
    9.4.2.1 Type I
    9.4.2.2 Type II
  9.4.3 Boehringer Ingelheim Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  9.4.4 Main Business/Business Overview
9.5 Celltrion
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Product Type, Application and Specification
    9.5.2.1 Type I
    9.5.2.2 Type II
  9.5.3 Celltrion Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  9.5.4 Main Business/Business Overview
9.6 Coherus Biosciences
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Million USD Product Type, Application and Specification
    9.6.2.1 Type I
    9.6.2.2 Type II
  9.6.3 Coherus Biosciences Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  9.6.4 Main Business/Business Overview
9.7 Dr. Reddy’s Laboratories
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Pharma & Healthcare Product Type, Application and Specification
    9.7.2.1 Type I
    9.7.2.2 Type II
  9.7.3 Dr. Reddy’s Laboratories Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  9.7.4 Main Business/Business Overview
9.8 Hospira
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Product Type, Application and Specification
    9.8.2.1 Type I
    9.8.2.2 Type II
  9.8.3 Hospira Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  9.8.4 Main Business/Business Overview
9.9 Intas Pharmaceuticals
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Product Type, Application and Specification
    9.9.2.1 Type I
    9.9.2.2 Type II
  9.9.3 Intas Pharmaceuticals Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  9.9.4 Main Business/Business Overview
9.10 Merck Serono
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Product Type, Application and Specification
    9.10.2.1 Type I
    9.10.2.2 Type II
  9.10.3 Merck Serono Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  9.10.4 Main Business/Business Overview
9.11 Mylan
9.12 Novartis (Sandoz)
9.13 Pfizer
9.14 Wockhardt

10 ONCOLOGY BIOSIMILARS MAUFACTURING COST ANALYSIS

10.1 Oncology Biosimilars Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Oncology Biosimilars

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Oncology Biosimilars Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Oncology Biosimilars Major Manufacturers in 2015
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL ONCOLOGY BIOSIMILARS MARKET FORECAST (2016-2021)

14.1 Global Oncology Biosimilars Sales, Revenue Forecast (2016-2021)
14.2 Global Oncology Biosimilars Sales Forecast by Regions (2016-2021)
14.3 Global Oncology Biosimilars Sales Forecast by Type (2016-2021)
14.4 Global Oncology Biosimilars Sales Forecast by Application (2016-2021)

15 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Oncology Biosimilars
Table Classification of Oncology Biosimilars
Figure Global Sales Market Share of Oncology Biosimilars by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Oncology Biosimilars
Figure Global Sales Market Share of Oncology Biosimilars by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure USA Oncology Biosimilars Revenue and Growth Rate (2011-2021)
Figure China Oncology Biosimilars Revenue and Growth Rate (2011-2021)
Figure Europe Oncology Biosimilars Revenue and Growth Rate (2011-2021)
Figure Japan Oncology Biosimilars Revenue and Growth Rate (2011-2021)
Figure India Oncology Biosimilars Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Oncology Biosimilars Revenue and Growth Rate (2011-2021)
Figure Global Oncology Biosimilars Sales and Growth Rate (2011-2021)
Figure Global Oncology Biosimilars Revenue and Growth Rate (2011-2021)
Table Global Oncology Biosimilars Sales of Key Manufacturers (2011-2016)
Table Global Oncology Biosimilars Sales Share by Manufacturers (2011-2016)
Figure 2015 Oncology Biosimilars Sales Share by Manufacturers
Figure 2016 Oncology Biosimilars Sales Share by Manufacturers
Table Global Oncology Biosimilars Revenue by Manufacturers (2011-2016)
Table Global Oncology Biosimilars Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Oncology Biosimilars Revenue Share by Manufacturers
Table 2016 Global Oncology Biosimilars Revenue Share by Manufacturers
Table Global Oncology Biosimilars Sales and Market Share by Type (2011-2016)
Table Global Oncology Biosimilars Sales Share by Type (2011-2016)
Figure Sales Market Share of Oncology Biosimilars by Type (2011-2016)
Figure Global Oncology Biosimilars Sales Growth Rate by Type (2011-2016)
Table Global Oncology Biosimilars Revenue and Market Share by Type (2011-2016)
Table Global Oncology Biosimilars Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Oncology Biosimilars by Type (2011-2016)
Figure Global Oncology Biosimilars Revenue Growth Rate by Type (2011-2016)
Table Global Oncology Biosimilars Sales and Market Share by Regions (2011-2016)
Table Global Oncology Biosimilars Sales Share by Regions (2011-2016)
Figure Sales Market Share of Oncology Biosimilars by Regions (2011-2016)
Figure Global Oncology Biosimilars Sales Growth Rate by Regions (2011-2016)
Table Global Oncology Biosimilars Revenue and Market Share by Regions (2011-2016)
Table Global Oncology Biosimilars Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Oncology Biosimilars by Regions (2011-2016)
Figure Global Oncology Biosimilars Revenue Growth Rate by Regions (2011-2016)
Table Global Oncology Biosimilars Sales and Market Share by Application (2011-2016)
Table Global Oncology Biosimilars Sales Share by Application (2011-2016)
Figure Sales Market Share of Oncology Biosimilars by Application (2011-2016)
Figure Global Oncology Biosimilars Sales Growth Rate by Application (2011-2016)
Figure USA Oncology Biosimilars Sales and Growth Rate (2011-2016)
Figure USA Oncology Biosimilars Revenue and Growth Rate (2011-2016)
Figure USA Oncology Biosimilars Sales Price Trend (2011-2016)
Table USA Oncology Biosimilars Sales by Manufacturers (2011-2016)
Table USA Oncology Biosimilars Market Share by Manufacturers (2011-2016)
Table USA Oncology Biosimilars Sales by Type (2011-2016)
Table USA Oncology Biosimilars Market Share by Type (2011-2016)
Table USA Oncology Biosimilars Sales by Application (2011-2016)
Table USA Oncology Biosimilars Market Share by Application (2011-2016)
Figure China Oncology Biosimilars Sales and Growth Rate (2011-2016)
Figure China Oncology Biosimilars Revenue and Growth Rate (2011-2016)
Figure China Oncology Biosimilars Sales Price Trend (2011-2016)
Table China Oncology Biosimilars Sales by Manufacturers (2011-2016)
Table China Oncology Biosimilars Market Share by Manufacturers (2011-2016)
Table China Oncology Biosimilars Sales by Type (2011-2016)
Table China Oncology Biosimilars Market Share by Type (2011-2016)
Table China Oncology Biosimilars Sales by Application (2011-2016)
Table China Oncology Biosimilars Market Share by Application (2011-2016)
Figure Europe Oncology Biosimilars Sales and Growth Rate (2011-2016)
Figure Europe Oncology Biosimilars Revenue and Growth Rate (2011-2016)
Figure Europe Oncology Biosimilars Sales Price Trend (2011-2016)
Table Europe Oncology Biosimilars Sales by Manufacturers (2011-2016)
Table Europe Oncology Biosimilars Market Share by Manufacturers (2011-2016)
Table Europe Oncology Biosimilars Sales by Type (2011-2016)
Table Europe Oncology Biosimilars Market Share by Type (2011-2016)
Table Europe Oncology Biosimilars Sales by Application (2011-2016)
Table Europe Oncology Biosimilars Market Share by Application (2011-2016)
Figure Japan Oncology Biosimilars Sales and Growth Rate (2011-2016)
Figure Japan Oncology Biosimilars Revenue and Growth Rate (2011-2016)
Figure Japan Oncology Biosimilars Sales Price Trend (2011-2016)
Table Japan Oncology Biosimilars Sales by Manufacturers (2011-2016)
Table Japan Oncology Biosimilars Market Share by Manufacturers (2011-2016)
Table Japan Oncology Biosimilars Sales by Type (2011-2016)
Table Japan Oncology Biosimilars Market Share by Type (2011-2016)
Table Japan Oncology Biosimilars Sales by Application (2011-2016)
Table Japan Oncology Biosimilars Market Share by Application (2011-2016)
Figure India Oncology Biosimilars Sales and Growth Rate (2011-2016)
Figure India Oncology Biosimilars Revenue and Growth Rate (2011-2016)
Figure India Oncology Biosimilars Sales Price Trend (2011-2016)
Table India Oncology Biosimilars Sales by Manufacturers (2011-2016)
Table India Oncology Biosimilars Market Share by Manufacturers (2011-2016)
Table India Oncology Biosimilars Sales by Type (2011-2016)
Table India Oncology Biosimilars Market Share by Type (2011-2016)
Table India Oncology Biosimilars Sales by Application (2011-2016)
Table India Oncology Biosimilars Market Share by Application (2011-2016)
Figure Southeast Asia Oncology Biosimilars Sales and Growth Rate (2011-2016)
Figure Southeast Asia Oncology Biosimilars Revenue and Growth Rate (2011-2016)
Figure Southeast Asia Oncology Biosimilars Sales Price Trend (2011-2016)
Table Southeast Asia Oncology Biosimilars Sales by Manufacturers (2011-2016)
Table Southeast Asia Oncology Biosimilars Market Share by Manufacturers (2011-2016)
Table Southeast Asia Oncology Biosimilars Sales by Type (2011-2016)
Table Southeast Asia Oncology Biosimilars Market Share by Type (2011-2016)
Table Southeast Asia Oncology Biosimilars Sales by Application (2011-2016)
Table Southeast Asia Oncology Biosimilars Market Share by Application (2011-2016)
Table 3SBio Basic Information List
Table 3SBio Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure 3SBio Oncology Biosimilars Global Market Share (2011-2016)
Table Biocon Basic Information List
Table Biocon Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Biocon Oncology Biosimilars Global Market Share (2011-2016)
Table BioXpress Therapeutics Basic Information List
Table BioXpress Therapeutics Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure BioXpress Therapeutics Oncology Biosimilars Global Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Boehringer Ingelheim Oncology Biosimilars Global Market Share (2011-2016)
Table Celltrion Basic Information List
Table Celltrion Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Celltrion Oncology Biosimilars Global Market Share (2011-2016)
Table Coherus Biosciences Basic Information List
Table Coherus Biosciences Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Coherus Biosciences Oncology Biosimilars Global Market Share (2011-2016)
Table Dr. Reddy’s Laboratories Basic Information List
Table Dr. Reddy’s Laboratories Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Dr. Reddy’s Laboratories Oncology Biosimilars Global Market Share (2011-2016)
Table Hospira Basic Information List
Table Hospira Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Hospira Oncology Biosimilars Global Market Share (2011-2016)
Table Intas Pharmaceuticals Basic Information List
Table Intas Pharmaceuticals Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Intas Pharmaceuticals Oncology Biosimilars Global Market Share (2011-2016)
Table Merck Serono Basic Information List
Table Merck Serono Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Serono Oncology Biosimilars Global Market Share (2011-2016)
Table Mylan Basic Information List
Table Mylan Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Mylan Oncology Biosimilars Global Market Share (2011-2016)
Table Novartis (Sandoz) Basic Information List
Table Novartis (Sandoz) Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis (Sandoz) Oncology Biosimilars Global Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Oncology Biosimilars Global Market Share (2011-2016)
Table Wockhardt Basic Information List
Table Wockhardt Oncology Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Wockhardt Oncology Biosimilars Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oncology Biosimilars
Figure Manufacturing Process Analysis of Oncology Biosimilars
Figure Oncology Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Oncology Biosimilars Major Manufacturers in 2015
Table Major Buyers of Oncology Biosimilars
Table Distributors/Traders List
Figure Global Oncology Biosimilars Sales and Growth Rate Forecast (2016-2021)
Figure Global Oncology Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Table Global Oncology Biosimilars Sales Forecast by Regions (2016-2021)
Table Global Oncology Biosimilars Sales Forecast by Type (2016-2021)
Table Global Oncology Biosimilars Sales Forecast by Application (2016-2021)